{"id":106131,"date":"2020-04-27T15:44:29","date_gmt":"2020-04-27T22:44:29","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2020\/04\/provention-bio-the-first-type-1-diabetes-breakthrough-in-100-years"},"modified":"2020-04-27T15:44:29","modified_gmt":"2020-04-27T22:44:29","slug":"provention-bio-the-first-type-1-diabetes-breakthrough-in-100-years","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2020\/04\/provention-bio-the-first-type-1-diabetes-breakthrough-in-100-years","title":{"rendered":"Provention Bio: The First Type 1 Diabetes Breakthrough In 100 Years"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/provention-bio-the-first-type-1-diabetes-breakthrough-in-100-years.jpg\"><\/a><\/p>\n<p>Provention Bio is on track to complete submission of a BLA for its T1D drug Teplizumab by the end of 2020.<\/p>\n<p>This will revolutionise treatment of at-risk T1D patients. The company received the Breakthrough Therapy Designation from FDA.<\/p>\n<p>The company is significantly undervalued on this indication alone \u2014 but has enormous potential in other indications.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Provention Bio is on track to complete submission of a BLA for its T1D drug Teplizumab by the end of 2020. This will revolutionise treatment of at-risk T1D patients. The company received the Breakthrough Therapy Designation from FDA. The company is significantly undervalued on this indication alone \u2014 but has enormous potential in other indications.<\/p>\n","protected":false},"author":511,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,1522],"tags":[],"class_list":["post-106131","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-innovation"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/106131","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/511"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=106131"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/106131\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=106131"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=106131"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=106131"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}